Fueled by record-breaking demand for its HOKA and UGG brands, Deckers Outdoor posts a robust Q3, beating expectations. The company credits disciplined full-price selling and strategic marketplace management for driving growth across all regions, leading to an upward revision of its fiscal 2026 guidance.
In its Q4 2025 earnings call, CNX Resources outlined a disciplined capital strategy for 2026, emphasizing operational resilience amid severe weather and providing updates on its deep Utica shale program, RNG initiatives, and hedging posture. Management signaled a focus on long-term infrastructure catalysts rather than chasing volatile spot gas prices.
Celestica's Q4 2025 results shattered guidance, fueled by its Connectivity & Cloud unit. The company announces a massive capital expenditure surge to over $1 billion in 2026, betting big on sustained demand from hyperscalers for AI and networking infrastructure.
Colony Bankcorp (CBAN) reported improved operating performance in Q4 2025, with executives detailing on-track integration of TC Federal and momentum in fee-based businesses. The bank targets a 1.20% return on assets for 2026 and signals appetite for further acquisitions.
President Trump is expected to nominate former Fed governor Kevin Warsh as the next Federal Reserve Chair, a move that could signal a pivot toward aggressive rate cuts paired with a reduction of the central bank's balance sheet, reshaping the landscape for markets and cryptocurrencies.
MGM Resorts International is powering its Las Vegas Strip operations with a major new solar and battery storage deal. This strategic shift toward renewables comes as the company's stock shows mixed signals, trading below some fair value estimates yet at a high earnings multiple, leaving investors to weigh long-term sustainability against immediate financial metrics.
A landmark agreement between the U.S. Department of Commerce and the Cameco-Westinghouse joint venture aims to catalyze over $80 billion in new nuclear reactor construction by 2030, bolstering Western energy security and reducing reliance on Russian nuclear fuel.
Elevra Lithium reports record quarterly revenue from its flagship North American operation but tempers near-term production guidance, highlighting the complex balancing act facing lithium miners as they expand amid market volatility.
GSK makes a dual strategic move, acquiring RAPT Therapeutics for its food allergy portfolio and securing broader European approval for its RSV vaccine Arexvy, reinforcing its focus on immunology and respiratory health.
Despite a recent 15% share price decline, EPB Group Berhad (KLSE:EPB) presents a complex picture with respectable financial fundamentals. We analyze its Return on Equity and growth trajectory to assess if this is a buying opportunity or a sign of deeper issues.
AIC Mines Ltd (ASX:A1M) reported record ore production and maintained cost guidance in its Q2 2026 update, with its share price rising 5.7%. The company's strategic focus remains on expanding its Eloise processing plant and advancing the Jericho project, aiming to boost copper output while managing expenses.
Marriott International's shares have delivered impressive multi-year gains, but recent analysis suggests the hospitality giant's stock may now be trading at a significant premium. With a DCF model pointing to a 16% overvaluation and a P/E ratio exceeding industry peers, investors are debating whether the price fully reflects future growth or has outpaced fundamentals.
Calix reports historic 2025 financial results, surpassing $1 billion in annual revenue, while outlining its strategic pivot to a third-generation 'Agent Workforce' platform and capitalizing on a projected multi-billion dollar BEAD program opportunity.
Despite a challenging demand environment to start fiscal 2026, Beazer Homes USA reports stabilizing sales trends and pins its margin recovery on cost controls, a strategic shift to newer communities, and the accelerating rollout of its popular 'Solar-Included' home offerings.
The alternative investment giant reported its strongest annual results in four decades, fueled by a surge in fundraising to $240 billion. Executives pointed to early signs of a reopening in deal activity and IPO markets, setting the stage for increased asset sales in 2026.
Brunswick Corporation (NYSE: BC) closed its 2025 fiscal year on a confident note, citing a resilient recovery in the marine market, a historic surge in free cash flow, and significant debt reduction. While navigating persistent tariff headwinds, the company's leadership pointed to stabilizing retail demand and strategic market share gains as key drivers for cautious optimism heading into 2026.
The defense giant's stock jumped over 4% following an optimistic sales forecast and a major new agreement to significantly boost production of a key missile defense system for the U.S. military.
Following its strategic rebrand from SMART Global Holdings, Penguin Solutions (PENG) is positioning itself at the forefront of AI and high-performance computing infrastructure. Yet, its stock tells a complex story of short-term volatility against long-term potential, raising questions about its true valuation in a heated market.
Cardinal Health (CAH) stock has drawn renewed investor interest following robust financial results, with revenue topping $234 billion and net income near $1.6 billion. The healthcare distributor's shares have rallied over 66% in the past year, though its premium valuation compared to peers is sparking debate among analysts.
As XPeng shares face sustained pressure, a deep dive into its valuation reveals a stark contradiction: while a fundamental cash flow model suggests significant upside, market-based metrics paint a more cautious picture. We analyze the numbers behind the divergence.
